RGEN logo

Repligen Corporation (RGEN)

Profile

Full Name

Repligen Corporation

Ticker

NASDAQ: RGEN

Exchange

NASDAQ

Sector

Healthcare

Industry

Medical Instruments & Supplies

Country

United States

IPO

April 29, 1986

Indexes

Not included

Website

http://www.repligen.com

Employees

1778

Key Details

Price

$121.74(-0.11%)

Market cap

$6.84B(Mid cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$634.44M(+0.33% YoY)

Annual EPS

-$0.46(-173.02% YoY)

PE ratio

-

Next earnings date

Jul 29, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $121.74
    RGEN price is $121.74

    30-Day Relative Volume

    1.14
    RGEN 30-day relative volume is 1.14

    Price Performance

    Price Most recent change

    -0.11%
    RGEN price was down -0.11% on Jul 25, 2025

    Price YTD change

    -15.42%
    RGEN price is down -15.42% since January 1st

    Price 1-year change

    -8.02%
    RGEN price is down -8.02% year-on-year

    Price 3-year change

    -38.22%
    RGEN price is down -38.22% over the past 3 years

    Price Range

    Price All-time high

    $327.32
    RGEN price is currently -62.81% below its historical high of $327.32

    Price 3-year low

    $102.97
    RGEN price is currently +18.23% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $6.84B
    RGEN market capitalization is $6.84 billion

    Market cap 3-year change

    -37.43%
    RGEN market capitalization is down -37.43% over the past 3 years

    Market cap All-time high

    $17.82B
    RGEN market capitalization is currently -61.63% below its historical high of $17.82 billion

    Market cap sector rank

    90.02%
    RGEN market capitalization is higher than 90.02% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +0.5%
    RGEN shares outstanding is up +0.5% year-on-year

    Shares Outstanding 3-Year Change

    +1.29%
    RGEN shares outstanding is up +1.29% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    1.38
    RGEN beta is 1.38

    200-day SMA

    $139.78
    RGEN price is currently -12.90% below its 200-day simple moving average

    50-day SMA

    $123.89
    RGEN price is currently -1.74% below its 50-day simple moving average

    RSI

    48.78
    RGEN 14-day relative strength index is 48.78

    Volume

    1.14
    RGEN 30-day relative volume is 1.14

    ATR

    $5.09
    RGEN average true range is $5.09

    10-day Historical Volatility

    60.18%
    RGEN 10-day historical volatility is 60.18%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $634.44M
    RGEN annual revenue is $634.44 million

    Revenue Analysts estimate

    $710.23M
    RGEN annual revenue is currently -10.67% lower than the consensus analysts' forecast

    Revenue 1-year change

    +0.33%
    RGEN annual revenue is up +0.33% year-on-year

    Revenue Sector rank

    76%
    RGEN annual revenue is higher than 76% of companies in Healthcare sector

    EPS

    EPS

    -$0.46
    RGEN annual earnings per share is -$0.46

    EPS Analysts estimate

    $1.68
    RGEN annual earnings per share is currently -127.32% lower than the consensus analysts' forecast

    EPS 1-year change

    -173.02%
    RGEN annual earnings per share is down -173.02% year-on-year

    EPS Sector rank

    68.63%
    RGEN annual earnings per share is higher than 68.63% of companies in Healthcare sector

    Profit

    Gross profit

    $274.64M
    RGEN annual gross profit is $274.64 million

    Gross margin

    43.29%
    RGEN annual gross profit margin is 43.29%

    Operating profit

    -$31.92M
    RGEN annual operating income is -$31.92 million

    Operating margin

    -5.03%
    RGEN annual operating profit margin is -5.03%

    Net income

    -$25.51M
    RGEN annual net profit is -$25.51 million

    Net margin

    -4.02%
    RGEN annual net profit margin is -4.02%

    Expenses

    Total expenses

    $666.36M
    RGEN annual total expenses is $666.36 million

    Operating expenses

    $306.57M
    RGEN annual total operating expenses is $306.57 million

    Cost of goods sold

    $359.79M
    RGEN annual cost of goods sold is $359.79 million

    Selling, general & administrative expenses

    $263.37M
    RGEN annual SGA is $263.37 million

    Depreciation and amortization

    $86.56M
    RGEN annual depreciation & amortization is $86.56 million

    Interest expense

    $20.73M
    RGEN annual interest expense is $20.73 million

    Income tax

    -$1.52M
    RGEN annual income tax is -$1.52 million

    EBIT & EBITDA

    EBIT

    -$6.30M
    RGEN annual earnings before interest & taxes is -$6.30 million

    EBITDA

    -$6.30M
    RGEN annual EBITDA is -$6.30 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $2.83B
    RGEN annual total assets is $2.83 billion

    Non current assets

    $1.76B
    RGEN annual long term assets is $1.76 billion

    Current assets

    $1.07B
    RGEN annual total current assets is $1.07 billion

    Cash and cash equivalents

    $757.36M
    RGEN annual cash & cash equivalents is $757.36 million

    Accounts receivable

    $134.12M
    RGEN annual accounts receivable is $134.12 million

    Inventory

    $142.96M
    RGEN annual inventory is $142.96 million

    Liabilities

    Total liabilities

    $856.95M
    RGEN annual total liabilities is $856.95 million

    Long term liabilities

    $730.16M
    RGEN annual total long term liabilities is $730.16 million

    Current liabilities

    $126.79M
    RGEN annual total current liabilities is $126.79 million

    Accounts payable

    $32.13M
    RGEN annual accounts payable is $32.13 million

    Debt

    Total debt

    $686.25M
    RGEN annual total debt is $686.25 million

    Total debt 1-year change

    -3.59%
    RGEN annual total debt is down -3.59% year-on-year

    Long term debt

    $671.14M
    RGEN annual long term debt is $671.14 million

    Short term debt

    $15.10M
    RGEN annual short term debt is $15.10 million

    Equity & Capital

    Shareholders equity

    $1.97B
    RGEN annual stockholders equity is $1.97 billion

    Book value

    $1.97B
    RGEN annual book value is $1.97 billion

    Retained earnings

    $407.35M
    RGEN annual retained earnings is $407.35 million

    Working capital

    $939.25M
    RGEN annual working capital is $939.25 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    $175.39M
    RGEN annual cash flow from operations is $175.39 million

    Cash from operations 1-year change

    +53.97%
    RGEN annual cash flow from operations is up +53.97% year-on-year

    Cash from investing

    -$86.38M
    RGEN annual cash flow from investing activities is -$86.38 million

    Cash from investing 1-year change

    +29.93%
    RGEN annual cash flow from investing activities is up +29.93% year-on-year

    Cash from financing

    -$82.90M
    RGEN annual cash flow from financing activities is -$82.90 million

    Cash from financing 1-year change

    -133.3%
    RGEN annual cash flow from financing activities is down -133.3% year-on-year

    CAPEX

    CAPEX

    $32.91M
    RGEN annual capital expenditures is $32.91 million

    CAPEX 1-year change

    -15.6%
    RGEN annual capital expenditures is down -15.6% year-on-year

    Free Cash Flow

    Free cash flow

    $142.49M
    RGEN annual free cash flow is $142.49 million

    Free cash flow 1-year change

    +90.16%
    RGEN annual free cash flow is up +90.16% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    43.29%
    RGEN annual gross profit margin is 43.29%

    Operating margin

    -5.03%
    RGEN annual operating profit margin is -5.03%

    Net margin

    -4.02%
    RGEN annual net profit margin is -4.02%

    ROA & ROE

    ROA

    -0.90%
    RGEN annual return on assets is -0.90%

    ROE

    -1.30%
    RGEN annual return on equity is -1.30%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    RGEN price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    RGEN price to earnings ratio is unknown

    PB Ratio

    PB ratio

    3.44
    RGEN price to book ratio is 3.44

    PB ratio Sector rank

    69.89%
    RGEN price to book ratio is higher than 69.89% of companies in Healthcare sector

    PS Ratio

    PS ratio

    10.52
    RGEN price to sales ratio is 10.52

    PS ratio Sector rank

    77.47%
    RGEN price to sales ratio is higher than 77.47% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    $6.83B
    RGEN enterprise value is $6.83 billion

    Enterprise value Sector rank

    89.57%
    RGEN enterprise value is higher than 89.57% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    78.81
    RGEN EV/EBITDA is 78.81

    EV/EBITDA Sector rank

    98.33%
    RGEN EV/EBITDA is higher than 98.33% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    8.41
    RGEN annual current ratio is 8.41

    Quick ratio

    7.28
    RGEN annual quick ratio is 7.28

    Leverage

    Debt to equity

    0.27
    RGEN annual debt to equity ratio is 0.27

    Interest coverage ratio

    -0.30
    RGEN annual interest coverage ratio is -0.30

    Risk & Stability

    Piotroski F-Score

    4
    RGEN piotroski f-score is 4

    Altman Z-Score

    5.61
    RGEN altman z-score is 5.61

    Analyst ratings

    Recent major analysts updates

    Jul 8, 25 Evercore ISI Group
    In-Line
    Jun 24, 25 Barclays
    Overweight
    May 5, 25 HC Wainwright & Co.
    Buy
    Apr 30, 25 RBC Capital
    Outperform
    Apr 29, 25 JP Morgan
    Overweight
    Apr 17, 25 Canaccord Genuity
    Hold
    Apr 16, 25 Canaccord Genuity
    Hold
    Mar 18, 25 Evercore ISI Group
    In-Line
    Feb 21, 25 RBC Capital
    Outperform
    Feb 21, 25 JP Morgan
    Overweight

    Institutional Ownership

    Screeners with RGEN included

    Growing Shares Outstanding
    Mid cap stocks
    US stocks
    Stocks with high beta
    Stocks below SMA 200
    Most recommended stocks
    NASDAQ Dividend Calendar
    Stocks above SMA 50
    Stocks below analysts price target
    Healthcare sector
    • What is the ticker symbol for Repligen Corporation?
    • Does Repligen Corporation pay dividends?
    • What sector is Repligen Corporation in?
    • What industry is Repligen Corporation in?
    • What country is Repligen Corporation based in?
    • When did Repligen Corporation go public?
    • Is Repligen Corporation in the S&P 500?
    • Is Repligen Corporation in the NASDAQ 100?
    • Is Repligen Corporation in the Dow Jones?
    • When was Repligen Corporation's last earnings report?
    • When does Repligen Corporation report earnings?

    What is the ticker symbol for Repligen Corporation?

    The ticker symbol for Repligen Corporation is NASDAQ:RGEN

    Does Repligen Corporation pay dividends?

    No, Repligen Corporation does not pay dividends

    What sector is Repligen Corporation in?

    Repligen Corporation is in the Healthcare sector

    What industry is Repligen Corporation in?

    Repligen Corporation is in the Medical Instruments & Supplies industry

    What country is Repligen Corporation based in?

    Repligen Corporation is headquartered in United States

    When did Repligen Corporation go public?

    Repligen Corporation's initial public offering (IPO) was on April 29, 1986

    Is Repligen Corporation in the S&P 500?

    No, Repligen Corporation is not included in the S&P 500 index

    Is Repligen Corporation in the NASDAQ 100?

    No, Repligen Corporation is not included in the NASDAQ 100 index

    Is Repligen Corporation in the Dow Jones?

    No, Repligen Corporation is not included in the Dow Jones index

    When was Repligen Corporation's last earnings report?

    Repligen Corporation's most recent earnings report was on April 29, 2025

    When does Repligen Corporation report earnings?

    The next expected earnings date for Repligen Corporation is July 29, 2025
    On this page